Ally Bridge Group

Ally Bridge Group as of March 31, 2026

Portfolio Holdings for Ally Bridge Group

Ally Bridge Group holds 26 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Soleno Therapeutics (SLNO) 10.8 $13M 400k 33.48
Praxis Precision Medicines I Com New (PRAX) 8.5 $11M 33k 322.19
Minerva Neurosciences Com New (NERV) 8.1 $10M 1.7M 6.03
Ovid Therapeutics (OVID) 5.1 $6.3M 2.8M 2.22
Compass Pathways Sponsored Ads (CMPS) 4.7 $5.8M 1.0M 5.53
Tarsus Pharmaceuticals (TARS) 4.6 $5.7M 81k 70.15
Solid Biosciences Com New (SLDB) 4.5 $5.5M 767k 7.20
Compass Therapeutics Call Option (CMPX) 4.3 $5.3M 1.0M 5.29
Promis Neurosciences Com Shs (PMN) 4.2 $5.3M 414k 12.70
Edgewise Therapeutics (EWTX) 4.1 $5.1M 161k 31.50
Uniqure Nv SHS Call Option (QURE) 4.0 $4.9M 300k 16.35
Eupraxia Pharmaceuticals (EPRX) 3.9 $4.8M 660k 7.24
Cytomx Therapeutics (CTMX) 3.4 $4.2M 900k 4.70
Inventiva Sa Ads (IVA) 3.3 $4.1M 745k 5.55
Perspective Therapeutics Com New (CATX) 3.1 $3.9M 927k 4.17
Abivax Sa Sponsored Ads (ABVX) 3.0 $3.8M 34k 111.35
Alumis (ALMS) 3.0 $3.7M 167k 22.03
Urogen Pharma (URGN) 2.9 $3.6M 202k 17.98
Capricor Therapeutics Com New (CAPR) 2.8 $3.5M 114k 30.40
Maze Therapeatics Call Option (MAZE) 2.4 $3.0M 100k 29.85
Aadi Bioscience (WHWK) 2.3 $2.8M 818k 3.45
Inhibikase Therapeutics Com New (IKT) 1.8 $2.2M 1.3M 1.68
Replimune Group Call Option (REPL) 1.5 $1.9M 247k 7.65
An2 Therapeutics (ANTX) 1.5 $1.8M 526k 3.42
Relmada Therapeutics (RLMD) 1.2 $1.5M 211k 6.96
Karyopharm Therapeutics Com New Call Option (KPTI) 1.1 $1.4M 250k 5.57